Specialized Disclosure Report (sd)
May 31 2017 - 2:01PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Skyline Medical Inc.
(Exact name of registrant as specified in
its charter)
Commission File Number:
001-36790
Delaware
|
|
33-1007393
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
|
|
|
2915 Commers Drive, Suite 900
|
|
Eagan, Minnesota 55121
|
(Address of principal executive offices)
|
|
(Zip Code)
|
Bob Myers 651-389-4800
(Registrant’s name and telephone number,
including area code, of the person to contact
in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which
this form is being filed, and provide the period to which the information in this form applies:
x
Rule 13p-1 under
the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2016.
Section 1 – Conflict Minerals Disclosure
Skyline Medical Inc. (“Skyline”, “we”,
“our” or the “Company”) has evaluated its current product lines and determined that certain products we
manufacture contain tin, tungsten, tantalum and/or gold (3TG), which are defined as “conflict minerals” by the United
States Securities and Exchange Commission that are necessary to the functionality or production of our products. Accordingly, we
are filing this disclosure along with a Conflict Minerals Report to disclose the measures we have taken to determine the origin
of the conflict minerals used in our products.
Item 1.01 Conflict Minerals Disclosure
We undertook due diligence measures, including surveying our
direct suppliers to try to determine the sources of these minerals, which we purchase through a complex supply chain.
We currently still have 31% of our suppliers who are not able
to identify the mineral sources’ originating country. Therefore, we cannot exclude the possibility that some of these conflict
minerals may have originated in the Democratic Republic of the Congo or an adjoining country and are not from recycled or scrap
sources.
Item 1.02 Exhibit
A copy of the Company’s Conflict Minerals Report for the
reporting period from January 1, 2016 to December 31, 2016 is provided as Exhibit 1.01 hereto and is publicly available at: www.skylinemedical.com
under News and Media. The content of any website referred to in this Form SD is included for general information only and is not
incorporated by reference in this Form SD.
Section 2 - Exhibits
Exhibit 1.01 – Conflict Minerals Report as required by
Items 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
Skyline Medical Inc.
By: /s/ Bob Myers
|
|
Date: May 31, 2017
|
|
|
|
Name: Bob Myers
|
|
|
Title: Chief Financial Officer
|
|
|
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Precision Therapeutics Inc. (NASDAQ:AIPT)
Historical Stock Chart
From Sep 2023 to Sep 2024